Overall, this study contributes to our understanding of the biology of nausea and vomiting in pregnancy and may lead to future research evaluating new treatment avenues. Of note, drugs targeting the GDF15 pathway have shown great promise in mitigating weight loss, loss of appetite, and vomiting in animal models and are currently in clinical trials in cancer cachexia, a disease with similar symptoms to HG.
Read MoreFebruary is Heart Health Month, and the HER Foundation shares 4 ways for you to protect your heart.
Read MoreDr. Marlena Fejzo, HER Research Adviser and Board of Directors, was invited to speak at February’s Keystone Conference on Maternal-Fetal Crosstalk in Santa Fe, NM. Dr. Fejzo presented “Evidence the placenta and appetite hormone GDF15 causes nausea and vomiting of pregnancy” and met with experts on maternal/fetal health from around the world.
Read MoreBe a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!
Read MoreThe HER Foundation is excited to share our Impact Report with highlights of 2021 and 2022. We are Helping Generations across the globe! The HER Foundation is the only dedicated HG research team in the world doing genetics research on Hyperemesis Gravidarum and is the only voice of advocacy for HG in the US and in many other countries!
Read More